Comparison of outcomes after DA ‐ EPOCH ‐R or GMALL high‐intensity therapy for front‐line treatment of Burkitt lymphoma: A retrospective cohort
British Journal of Haematology · 2026
DOI: 10.1111/bjh.70730 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Eduard Schulz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Haematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Burkitt Lymphoma, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Haematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
- Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
Zitieren
APA
Schulz, E., Posch, F., Friedrich, K., Neumeister, P., & Prochazka, K. T. (2026). Comparison of outcomes after DA ‐ EPOCH ‐R or GMALL high‐intensity therapy for front‐line treatment of Burkitt lymphoma: A retrospective cohort. British Journal of Haematology. https://doi.org/10.1111/bjh.70730
Vancouver
Schulz E, Posch F, Friedrich K, Neumeister P, Prochazka KT. Comparison of outcomes after DA ‐ EPOCH ‐R or GMALL high‐intensity therapy for front‐line treatment of Burkitt lymphoma: A retrospective cohort. British Journal of Haematology. 2026. doi:10.1111/bjh.70730
BibTeX
@article{Schulz2026,
author = {Schulz, Eduard and Posch, Florian and Friedrich, Kristina and Neumeister, Peter and Prochazka, Katharina T},
title = {Comparison of outcomes after DA ‐ EPOCH ‐R or GMALL high‐intensity therapy for front‐line treatment of Burkitt lymphoma: A retrospective cohort},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70730}
}
EUVIMED